Inventory Summary of CNBX Pharmaceuticals Inc.

CNBX Pharmaceuticals Inc.'s latest annual inventory in 2023 was -94.61 Thousand USD , down -17.13% from previous year.
CNBX Pharmaceuticals Inc.'s latest quarterly inventory in 2024 Q1 was -69.28 Thousand USD , up 26.77% from previous quarter.
CNBX Pharmaceuticals Inc. reported annual inventory of -80.77 Thousand USD in 2022, up 60.48% from previous year.
CNBX Pharmaceuticals Inc. reported annual inventory of -204.37 Thousand USD in 2021, down -34.19% from previous year.
CNBX Pharmaceuticals Inc. reported quarterly inventory of -69.28 Thousand USD for 2024 Q1, up 26.77% from previous quarter.
CNBX Pharmaceuticals Inc. reported quarterly inventory of -126.77 Thousand USD for 2024 Q2, down -82.97% from previous quarter.

Annual Inventory Chart of CNBX Pharmaceuticals Inc. (2023 - 2005)

Historical Annual Inventory of CNBX Pharmaceuticals Inc. (2023 - 2005)

Year	Inventory	Inventory Growth
2023	-94.61 Thousand USD	-17.13%
2022	-80.77 Thousand USD	60.48%
2021	-204.37 Thousand USD	-34.19%
2020	-152.29 Thousand USD	95.32%
2019	-3.25 Million USD	-1333.02%
2018	-227.24 Thousand USD	-51.82%
2017	-149.68 Thousand USD	-4946.66%
2016	-2966.00 USD	0.0%
2015	- USD	0.0%
2014	- USD	0.0%
2013	- USD	0.0%
2012	- USD	0.0%
2011	- USD	0.0%
2010	- USD	0.0%
2009	- USD	0.0%
2008	- USD	0.0%
2007	- USD	0.0%
2006	- USD	0.0%
2005	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q3	-6621.00 USD	100.0%
2024 Q1	-69.28 Thousand USD	26.77%
2024 Q2	-126.77 Thousand USD	-82.97%
2023 Q3	-304.64 Thousand USD	-398.71%
2023 Q1	-78.08 Thousand USD	3.33%
2023 Q4	-94.61 Thousand USD	68.94%
2023 FY	-94.61 Thousand USD	-17.13%
2023 Q2	-61.08 Thousand USD	21.77%
2022 Q1	- USD	0.0%
2022 FY	-80.77 Thousand USD	60.48%
2022 Q2	- USD	0.0%
2022 Q3	- USD	0.0%
2022 Q4	-80.77 Thousand USD	0.0%
2021 Q4	- USD	0.0%
2021 Q2	- USD	100.0%
2021 Q1	-168.57 Thousand USD	-10.69%
2021 FY	-204.37 Thousand USD	-34.19%
2021 Q3	- USD	0.0%
2020 Q2	-199.07 Thousand USD	13.98%
2020 Q1	-231.42 Thousand USD	92.89%
2020 Q3	-154.78 Thousand USD	22.25%
2020 Q4	-152.29 Thousand USD	1.61%
2020 FY	-152.29 Thousand USD	95.32%
2019 Q4	-3.25 Million USD	15.52%
2019 Q1	- USD	100.0%
2019 Q2	1.00 USD	0.0%
2019 FY	-3.25 Million USD	-1333.02%
2019 Q3	-3.85 Million USD	-385486900.0%
2018 Q2	-113.55 Thousand USD	-111.36%
2018 Q4	-227.24 Thousand USD	-96.73%
2018 FY	-227.24 Thousand USD	-51.82%
2018 Q1	-53.72 Thousand USD	64.11%
2018 Q3	-115.5 Thousand USD	-1.72%
2017 Q4	-149.68 Thousand USD	17.98%
2017 Q3	-182.49 Thousand USD	-735.63%
2017 Q2	-21.83 Thousand USD	-532.46%
2017 Q1	-3453.00 USD	-16.42%
2017 FY	-149.68 Thousand USD	-4946.66%
2016 Q3	-2047.00 USD	54.64%
2016 FY	-2966.00 USD	0.0%
2016 Q4	-2966.00 USD	-44.89%
2016 Q1	-10.28 Thousand USD	0.0%
2016 Q2	-4513.00 USD	56.13%
2015 Q3	- USD	0.0%
2015 FY	- USD	0.0%
2015 Q1	- USD	0.0%
2015 Q2	- USD	0.0%
2015 Q4	- USD	0.0%
2014 Q3	- USD	0.0%
2014 FY	- USD	0.0%
2014 Q4	- USD	0.0%
2014 Q1	- USD	0.0%
2014 Q2	- USD	0.0%
2013 Q2	- USD	0.0%
2013 Q1	- USD	0.0%
2013 FY	- USD	0.0%
2013 Q4	- USD	0.0%
2013 Q3	- USD	0.0%
2012 Q1	- USD	0.0%
2012 Q3	- USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	- USD	0.0%
2012 Q2	- USD	0.0%
2011 Q4	- USD	0.0%
2011 Q1	- USD	0.0%
2011 Q3	- USD	0.0%
2011 Q2	- USD	0.0%
2011 FY	- USD	0.0%
2010 FY	- USD	0.0%
2010 Q4	- USD	0.0%
2010 Q3	- USD	0.0%
2010 Q2	- USD	0.0%
2010 Q1	- USD	0.0%
2009 Q1	- USD	0.0%
2009 FY	- USD	0.0%
2009 Q4	- USD	0.0%
2009 Q3	- USD	0.0%
2009 Q2	- USD	0.0%
2008 Q4	- USD	0.0%
2008 Q3	- USD	0.0%
2008 Q2	- USD	0.0%
2008 Q1	- USD	0.0%
2008 FY	- USD	0.0%
2007 Q1	- USD	0.0%
2007 Q2	- USD	0.0%
2007 FY	- USD	0.0%
2007 Q3	- USD	0.0%
2007 Q4	- USD	0.0%
2006 Q1	- USD	0.0%
2006 Q4	- USD	0.0%
2006 Q3	- USD	0.0%
2006 Q2	- USD	0.0%
2006 FY	- USD	0.0%
2005 FY	- USD	0.0%

Peer Inventory Comparison of CNBX Pharmaceuticals Inc.

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	106.08%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	1018.296%
SQZ Biotechnologies Company	- USD	Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	105.575%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	104.399%
Mesoblast Limited	1.00 USD	9461300.0%
Propanc Biopharma, Inc.	- USD	Infinity%
Genus plc	89.4 Million USD	100.106%
VioQuest Pharmaceuticals, Inc.	- USD	Infinity%
Marizyme, Inc.	24.85 Thousand USD	480.656%
ContraFect Corporation	- USD	Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	691.325%
PsyBio Therapeutics Corp.	- USD	Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	Infinity%
Intellipharmaceutics International Inc.	1.00 USD	9461300.0%
AXIM Biotechnologies, Inc.	- USD	Infinity%
MultiCell Technologies, Inc.	- USD	Infinity%
Accustem Sciences Inc.	- USD	Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	112.068%
EV Biologics, Inc.	- USD	Infinity%
Q BioMed Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	105.53%
Neon Bloom, Inc.	7938.00 USD	1291.887%
Mosaic ImmunoEngineering Inc.	- USD	Infinity%
Biomind Labs Inc.	- USD	Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Pharming Group N.V.	56.76 Million USD	100.167%
Oncotelic Therapeutics, Inc.	- USD	Infinity%
Skye Bioscience, Inc.	- USD	Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	519.119%
THC Farmaceuticals, Inc.	- USD	Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	106.934%
IMV Inc.	2.00 USD	4730700.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	888.433%
Curative Biotechnology, Inc.	-115.62 Thousand USD	18.173%
GB Sciences, Inc.	- USD	Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	204.644%
HST Global, Inc.	- USD	Infinity%
CSL Limited	5.96 Billion USD	100.002%
Halberd Corporation	- USD	Infinity%
Enzolytics Inc.	- USD	Infinity%
Resverlogix Corp.	2.37 Million USD	103.99%
Affymax, Inc.	- USD	Infinity%
SYBLEU INC	- USD	Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	145.142%
argenx SE	310.55 Million USD	100.03%
MetaStat, Inc.	- USD	Infinity%
Northwest Biotherapeutics, Inc.	- USD	Infinity%
Enzon Pharmaceuticals, Inc.	- USD	Infinity%
Arno Therapeutics, Inc.	- USD	Infinity%
RespireRx Pharmaceuticals Inc.	- USD	Infinity%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	- USD	Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	921.285%
Zenith Capital Corp.	3.00 USD	3153833.333%
Genscript Biotech Corporation	53.33 Million USD	100.177%
Ember Therapeutics, Inc.	- USD	Infinity%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	289.224%
WPD Pharmaceuticals Inc.	0.25 USD	37844900.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	100.46%
Provectus Biopharmaceuticals, Inc.	- USD	Infinity%
Adynxx, Inc.	- USD	Infinity%
Helix BioMedix, Inc.	- USD	Infinity%
GlobeStar Therapeutics Corporation	- USD	Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	100.737%
Cotinga Pharmaceuticals Inc.	0.98 USD	9654385.714%
BioStem Technologies, Inc.	658.67 Thousand USD	114.364%
ONE Bio Corp.	4.5 Million USD	102.1%
Reve Technologies, Inc.	- USD	Infinity%
Burzynski Research Institute, Inc.	- USD	Infinity%
Wesana Health Holdings Inc.	1.00 USD	9461300.0%
Agentix Corp.	- USD	Infinity%
LadRx Corporation	- USD	Infinity%
Cell Source, Inc.	- USD	Infinity%
ProtoKinetix, Incorporated	- USD	Infinity%
Regen BioPharma, Inc.	- USD	Infinity%
Regen BioPharma, Inc.	- USD	Infinity%
NovAccess Global Inc.	- USD	Infinity%
Endonovo Therapeutics, Inc.	- USD	Infinity%
Itoco Inc.	- USD	Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	-357.704%
Pathfinder Cell Therapy, Inc.	- USD	Infinity%
Kadimastem Ltd	- USD	Infinity%
Oncology Pharma Inc.	- USD	Infinity%
Institute of Biomedical Research Corp.	- USD	Infinity%
CytoDyn Inc.	- USD	Infinity%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	- USD	Infinity%
Mobile Lads Corp.	- USD	Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	-1086145.695%
Qrons Inc.	- USD	Infinity%
Alseres Pharmaceuticals, Inc.	- USD	Infinity%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	- USD	Infinity%
Rebus Holdings, Inc.	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	Infinity%
International Stem Cell Corporation	1.26 Million USD	107.491%
Bioxytran, Inc.	- USD	Infinity%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	15 Million USD	100.631%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	- USD	Infinity%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	- USD	Infinity%
Adhera Therapeutics, Inc.	- USD	Infinity%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	- USD	Infinity%
Innovation Pharmaceuticals Inc.	- USD	Infinity%
Neutra Corp.	- USD	Infinity%
Windtree Therapeutics, Inc.	- USD	Infinity%
PureTech Health plc	- USD	Infinity%
Coeptis Therapeutics, Inc.	- USD	Infinity%
IXICO plc	1.00 USD	9461300.0%
IntelGenx Technologies Corp.	71 Thousand USD	233.256%
Gelesis Holdings, Inc.	6.86 Million USD	101.378%
CSL Limited	5.96 Billion USD	100.002%
Cellectis S.A.	1.00 USD	9461300.0%

Global Stocks Search

CNBX Pharmaceuticals Inc. (CNBX)

Inventory Summary of CNBX Pharmaceuticals Inc.

Annual Inventory Chart of CNBX Pharmaceuticals Inc. (2023 - 2005)

Historical Annual Inventory of CNBX Pharmaceuticals Inc. (2023 - 2005)

Peer Inventory Comparison of CNBX Pharmaceuticals Inc.